News Hub

Jul 20, 2026

Hana Yamamoto

Press Releases

Samsung Bioepis and Harrow Present Interim Data from a Large-Scale Post-Marketing Surveillance Study on SB11 (BYOOVIZ® / AMELIVU®), a Biosimilar to Lucentis (ranibizumab), at ASRS 2026

Samsung Bioepis and Harrow presented interim post-marketing surveillance results demonstrating that SB11, a biosimilar to Lucentis, provides comparable safety and clinical effectiveness in both treatment-naïve and switched patients with retinal diseases. The real-world study reinforces confidence for retina specialists in using SB11 as a cost-effec…

HROW

Jul 20, 2026

Ajmal Hussain

Press Releases

Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team

Monopar Therapeutics announced the addition of experienced commercial executives to its leadership team and board as it prepares for the planned mid-2026 FDA New Drug Application submission and potential market launch of ALXN1840, a novel treatment for Wilson disease. The appointments aim to strengthen the company's commercial capabilities in antic…

MNPR

Jul 20, 2026

Priya Menon

Press Releases

InvestigateTV and WVUE FOX 8 Honored with Four National Sigma Delta Chi Awards for Journalism Excellence

Gray Media, Inc. announced that its investigative team InvestigateTV and New Orleans station WVUE FOX 8 received four Sigma Delta Chi Awards for outstanding journalism, recognizing impactful reporting on healthcare inequities, police interrogation tactics, breaking news coverage, and local government investigations. These honors underscore Gray's c…

GTN

Jul 20, 2026

Caleb Monroe

Press Releases

VCI Global Regains Full Compliance with Nasdaq Periodic Filing Requirement

VCI Global Limited announced that it has regained compliance with Nasdaq periodic filing requirements following a delayed filing of its Annual Report for the fiscal year ended December 31, 2025. The company filed the required report on July 15, 2026, after which Nasdaq confirmed compliance was restored. Management emphasized commitment to corporate…

VCIG

Jul 20, 2026

Sofia Navarro

Press Releases

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

Belite Bio announced additional positive secondary endpoint data from its Phase 3 DRAGON trial of tinlarebant, an oral therapy targeting Stargardt disease type 1 (STGD1). The data presented at the 2026 ASRS Annual Meeting demonstrated stabilization of quantitative autofluorescence—a marker of toxic bisretinoid accumulation—suggesting the drug's rob…

BLTE

Jul 20, 2026

Hana Yamamoto

Press Releases

SunPower Completes Megawatt Millenium Solar Project

SunPower Inc. announced the successful completion of a 977-kilowatt solar energy system at the Millenium Project in Palm Desert, California. The system is expected to generate over 1.6 million kWh annually, backed by a 30-year performance commitment. The project earned SunPower a high Net Promoter Score (NPS) of 90, reflecting strong customer satis…

SPWR

Jul 20, 2026

Derek Hwang

Press Releases

authID Selected by Top Global Retailer to Deploy Biometric Authentication for 100K+ Employees

authID has secured a contract to deploy its biometric identity verification and authentication technology for more than 100,000 employees across a major global retailer's workforce. The solution enhances onboarding security and streamlines account access at the retailer's call centers, addressing increasing fraud challenges in workforce authenticat…

AUID

Jul 20, 2026

Hana Yamamoto

Press Releases

FOREWARN Expands into Home Healthcare, Bringing Real-Time Safety Intelligence to Caregivers Nationwide

red violet, Inc., trading as RDVT, announced the expansion of its FOREWARN safety intelligence platform into the home healthcare sector. The new offering provides pre-visit household insights and risk information to home healthcare providers and agencies, aiming to improve safety for caregivers who enter unpredictable environments. This service lev…

RDVT

Jul 20, 2026

Maya Rios

Press Releases

AmpliTech Receives Approximately $21.9 Million of Subscriptions in Series A Rights Offering

AmpliTech Group, Inc., a U.S.-based designer and manufacturer of advanced RF and 5G infrastructure systems, announced subscriptions totaling approximately $21.9 million in its Series A Rights Offering. The company plans to use the net proceeds for general corporate purposes including working capital, scaling operations, commercialization, and poten…

AMPG

Jul 20, 2026

Maya Rios

Press Releases

Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market

Clearmind Medicine Inc., a clinical-stage biotech company focused on non-hallucinogenic neuroplastogen-derived therapeutics, announced filing a patent application in Hong Kong for innovative psychedelic compounds aimed at treating PTSD and other mental health disorders. This strengthens the company's global IP portfolio under its exclusive licensin…

CMND

Jul 20, 2026

Hana Yamamoto

Press Releases

3 E Network Finalizes Custom Edge AI SoC Architecture for Aladdin Robots, Delivering a Core Computing Foundation to Accelerate Commercialization

3 E Network Technology Group Limited announced the completion of the architectural design and deployment planning for a custom Edge AI System-on-Chip (SoC) tailored for next-generation smart healthcare and eldercare robots developed in partnership with Aladdin Alaris AI. The custom chip addresses critical real-time responsiveness, privacy complianc…

MASK

Jul 20, 2026

Derek Hwang

Press Releases

Nexera: KeepZone AI Facilitates First Purchase Order for RT LTA Systems’ SkyStar 180™ Aerostats

Nexera Technologies Ltd, via its subsidiary KeepZone AI, has facilitated the first purchase order for RT LTA Systems' SkyStar 180 aerostats from a leading homeland security solutions integrator in Mexico. This milestone validates KeepZone's business development efforts and has resulted in the extension of KeepZone's exclusive representation agreeme…

NEXR

Jul 20, 2026

Maya Rios

Press Releases

Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction

Standard BioTools announced the filing of a registration statement for its all-stock merger with Treeline Biosciences. The combined company, expected to operate as Treeline Biosciences Holdings, Inc. under the ticker TRLN, will have over $900 million in cash at closing to fund operations through 2029. Treeline brings a deep clinical-stage pipeline …

LAB

Jul 20, 2026

Avery Klein

Trade Ideas

Entergy: Contracted Data-Center Load Makes EPS Growth Visible — A Tactical Long

Entergy is converting large data-center commitments into predictable load and contracted economics that should drive visible EPS growth over the next 12-18 months. Valuation at ~30x 2026 EPS already prices growth, but long-term contracts, dividend support, and a constructive regulatory framework justify a selective long trade with defined risk cont…

ETR

Jul 20, 2026

Caleb Monroe

Press Releases

BrainsWay Announces Strategic Investment in Radial Health, Inc.

BrainsWay Ltd., a leader in noninvasive brain stimulation technologies, announced a $3 million minority equity investment in Radial Health, Inc., a company supporting a network of Brain Medicine clinics. This investment supports Radial's Series A financing and its plan to expand clinical infrastructure, reimbursement tools, and AI-based decision su…

BWAY

Jul 20, 2026

Nina Shah

Press Releases

Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)

Dyne Therapeutics announced FDA acceptance of its Biologics License Application for z-rostudirsen, an investigational treatment for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. The FDA granted Priority Review with a target decision date of January 21, 2027. Z-rostudirsen demonstrated significant dystrophin production increases an…

DYN

Jul 20, 2026

Maya Rios

Press Releases

Frontier Nuclear and Minerals Announces Board Renewal and Appointment of New Directors Ahead of Annual Meeting

Frontier Nuclear and Minerals Inc. announced the appointment of Joshua Girnun and Donal Carroll to its Board of Directors ahead of its August 2026 annual meeting. These appointments aim to bring enhanced expertise in metals and mining investment, corporate finance, and public company governance to support Frontier's growth in the nuclear fuel cycle…

FNUC

Jul 20, 2026

Maya Rios

Politics

Justice Department Subpoenas 14 Law Firms in ABA Suit Over Trump Executive Orders

The U.S. Justice Department issued subpoenas to 14 major law firms seeking detailed records and depositions related to White House executive orders and communications with a presidential adviser. The subpoenas were disclosed in a lawsuit filed by the American Bar Association alleging an unlawful administration policy to punish firms over prior work…

Jul 20, 2026

Maya Rios

Trade Ideas

Buy GGAL Ahead of a Credit Upswing: Cheap Book, High Optionality

Grupo Financiero Galicia (GGAL) trades near book value with a 3.8% yield and heavy exposure to an Argentine credit recovery. With market cap of $8.53B, improving credit demand under recent reform tailwinds and a relatively light float, GGAL offers an asymmetric risk/reward for active traders. We upgrade to Buy and lay out an actionable entry, stop …

GGAL

Jul 20, 2026

Derek Hwang

Politics

Senator Warns Senate Showdown Likely Over Bill to Make Daylight Saving Time Permanent

A measure that would keep the United States on daylight saving time year-round, approved by the House last week, faces significant opposition in the Senate, according to Senator John Kennedy. The bill has drawn support from the White House but also objections from senators concerned about morning darkness for schoolchildren and workers. Senate lead…

Jul 20, 2026

Caleb Monroe

Press Releases

IREN Signs $2.8bn in New Customer Contracts with Leading AI Developers, Raises 2026 ARR Target to over $4bn

IREN Limited announced a significant increase in its 2026 AI Cloud annualized run-rate revenue target from $3.7 billion to over $4 billion, backed by $2.8 billion in new multi-year cloud services contracts with leading AI developers including Microsoft and NVIDIA. The company's AI Cloud capacity is scaling rapidly, supported by strong customer dema…

IREN

Jul 20, 2026

Nina Shah

Press Releases

VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

VERAXA Biotech AG announced it received favorable Scientific Advice from the German Paul-Ehrlich-Institute regarding the biology and non-clinical development plan of its advanced BiTAC-TCE cancer therapy candidate. This early regulatory endorsement validates the novel dual-targeting therapy approach, de-risking the development path and supporting e…

VRXA

Jul 20, 2026

Ajmal Hussain

Press Releases

Helport AI Completes Key Consumer Finance AI Labor Workflow, Advancing Toward Scalable Replication

Helport AI Limited announced a major advancement in its AI Labor platform with successful deployment and validation of customer acquisition workflows across multiple consumer lending products in Mexico. The company demonstrated its AI system's capability to perform complex customer acquisition tasks traditionally done by human experts, achieving st…

HPAI

Jul 20, 2026

Ajmal Hussain

Press Releases

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies

Kamada Ltd. announced a three-year $50 million sales agreement to supply normal source plasma from its FDA-approved collection centers in Texas to a leading biopharmaceutical company specializing in plasma-derived therapies. The agreement validates Kamada's investment in U.S.-based plasma centers and supports its vertical integration and multi-year…

KMDA

Jul 20, 2026

Nina Shah

Press Releases

Destination XL Group, Inc. Files Preliminary Proxy Statement With Respect to FullBeauty Merger

Destination XL Group, Inc. filed a preliminary proxy statement announcing that its Board of Directors no longer recommends the merger with FullBeauty due to FullBeauty's high indebtedness, potential negative equity value, economic dilution to DXL stockholders, and a challenging consumer environment. The Board urges stockholders to vote against the …

DXLG